News - Page 112 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psyched Wellness and the National Research Council of Canada Announce Preliminary Data from Studies of Neuroprotective Properties of AME-1

Psyched Wellness and the National Research Council of Canada Announce Preliminary Data from Studies of Neuroprotective Properties of AME-1

Post published:March 24, 2022
Post category:Press Release

Read more about the article Gilgamesh Announces Clinical Candidates For Two Programs With First In Human Dosing to Begin in Late 2022

Gilgamesh Announces Clinical Candidates For Two Programs With First In Human Dosing to Begin in Late 2022

Post published:March 24, 2022
Post category:Press Release

Read more about the article Psilera Expands Computational Chemistry Abilities with the Addition of Dr. Daniel N. Santiago

Psilera Expands Computational Chemistry Abilities with the Addition of Dr. Daniel N. Santiago

Post published:March 24, 2022
Post category:Press Release

Read more about the article COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK

COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK

Post published:March 24, 2022
Post category:Press Release

Read more about the article Nova Mentis Begins Enrollment in North American Autism Study

Nova Mentis Begins Enrollment in North American Autism Study

Post published:March 23, 2022
Post category:Press Release

Read more about the article Filament Health Announces Second Patent Issuance

Filament Health Announces Second Patent Issuance

Post published:March 23, 2022
Post category:Press Release

Read more about the article Tryp Therapeutics Initiates Enrollment for Binge Eating Disorder Study in Partnership with University of Florida

Tryp Therapeutics Initiates Enrollment for Binge Eating Disorder Study in Partnership with University of Florida

Post published:March 23, 2022
Post category:Press Release

Read more about the article Awakn Life Sciences Announces Closing of Private Placement

Awakn Life Sciences Announces Closing of Private Placement

Post published:March 22, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin: MINDCURE – A Canary in the Psychedelic Coal Mine?

Psychedelic Bulletin: MINDCURE – A Canary in the Psychedelic Coal Mine?

Post published:March 18, 2022
Post category:Psychedelic Bulletin

Read more about the article Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments

Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments

Post published:March 17, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.